Studies of octreotide have not demonstrated a consistent benefit in efficacy or safety compared with conventional therapies. This study conformed to the ethical guidelines of the 1975. Aug 26, 2009 however, it is still unclear whether the efficacies of these drugs are same or not. Randomized controlled trials rcts were selected if octreotide was studied in patients with acute variceal bleeding confirmed by endoscopy as the probable source of bleeding, data were available on. Sc octreotide has led to nutritional deficiency due to malabsorption. The clinical management of gastroesophageal varices. Whether octreotide, if used for 48 hours after sclerotherapy, prevents this early re bleed, is debatable nowadays. Octreotide also has been suggested to have utility in the management of bleeding from gastrointestinal angiodysplasia, again in part related to its vasoactive mechanism in addition to inhibition of angiogenesis and possibly improved platelet aggregation. The combination of pharmacotherapy commonly terlipressin or octreotide and endoscopic therapy mainly endoscopic band ligation ebl is superior to either treatment alone in. To compare octreotide with injection sclerotherapy in the treatment of acute variceal haemorrhage, patients admitted with gastrointestinal bleeding and oesophageal varices confirmed by endoscopy. In this setting, in the absence of endoscopy, intensivists generally provide supportive care transfusion of blood products and acid suppression such as proton pump inhibitors. Sandostatin, sandostatin lar octreotide dosing, indications.
Acute variceal bleeding avb accounts for 70% of all upper gastrointestinal. Pdf a comparative study of efficacy of octreotide and. Acute bleeding from esophageal varices is a major problem in patients with cirrhosis of the liver and is associated with a 30 to 50 percent risk of death. Octreotide for control of bleeding peristomal varices in. Somatostatin and octreotide for variceal bleeding sciencedirect. These data demonstrate that the addition of sclerotherapy significantly improves the efficacy of smt alone for the treatment of acute variceal bleeding, although it also. Six male patients pughs grade a 2, b 2, c 2 with alcoholic cirrhosis received a 25mgh intravenous we read with interest the article by primignani et infusion of octreotide for acute variceal bleeding. Pdf management of acute esophageal variceal hemorrhage.
Randomized controlled trials rcts were selected if octreotide was studied in patients with acute variceal bleeding confirmed by endoscopy as the probable source of bleeding, data were available on allcause mortality or control of bleeding, and followup was. Variceal bleeding increased risk of bacterial infection sbp or bacteremia without obvious source develops in 20% of patients within 48 hours and 3566% within 2 weeks more common in hospitalized patients with variceal bleeding than other complications compared to patients without infection presence. Variceal bleeding increased risk of bacterial infection sbp or bacteremia without obvious source develops in 20% of patients within 48 hours and 3566% within 2 weeks more common in. However, octreotide has to be given through the vein and is effective for less than two hours. They also compared es alone with es plus octreotide in patients with actively bleeding esophageal varices. Lack of difference among terlipressin, somatostatin, and. These data demonstrate that the addition of sclerotherapy significantly improves the efficacy of smt alone for the treatment of acute variceal bleeding, although it also increases the rate of complications. Get a printable copy pdf file of the complete article 989k, or click on a page image below to browse page by page. An update on the management of acute esophageal variceal bleeding. Palliative care practitioners are often called on to manage difficult symptom issues where the primary focus is quality of life over aggressive interventions.
The standard dose of octreotide is 50 lg bolus injection followed by 2550 lgh. Variceal hemorrhage results from complications of endstage liver disease, and nonvariceal bleeding is associated with peptic ulcer disease pud or other causes of ugib. Somatostatin or octreotide in acute variceal bleeding. Pdf use of octreotide in the acute management of bleeding. Esophageal varices are extremely dilated submucosal veins in the lower third of the esophagus. Endoscopic sclerotherapy is an accepted treatment for bleeding esophageal varices, but it is associated with substantial local and systemic complications. Octreotide was administered as a continuous infusion 25 mcghr for 48 hours. It exerts an inhibitory effect upon numerous functions of the body, and, therefore, increasing attention has been focused on its potential as a therapeutic agent with cytoprotective properties and a potent inhibitory action on a wide variety of functions in. Jun 12, 2009 the combination of pharmacotherapy commonly terlipressin or octreotide and endoscopic therapy mainly endoscopic band ligation ebl is superior to either treatment alone in achieving initial control of bleeding and 5day hemostasis in patients with variceal hemorrhage. Rule of octreotide and vasopressin is adjunctive to banding or sclerotherapy, isnt it. Octreotide is routinely used in the treatment of variceal bleeding due to its vasoconstrictive effects on the splanchnic vasculature.
This study is performed to compare the efficacy of terlipressin, somatostatin, and octreotide in patients with variceal bleeding for the control of variceal bleeding in combination with endoscopic therapy. In practice, somatostatin or octreotide should be administered as early as. Synopsis of inpatient management for esophageal variceal hemorrhage the authors suggest that all vh requires icu admission with the goal of acute control of bleeding, prevention of. The role of combining vasoactive drugs with endoscopic therapy vbl or. Request pdf octreotide for acute esophageal variceal bleeding. One direct comparison of octreotide with somatostatin for esophageal variceal bleeding showed a significantly higher transfusion requirement in the patients receiving octreotide. We identified randomized trials of octreotide for variceal hemorrhage from computerized databases, scientific. The authors state that as long term octreotide had not been used. Baveno vis guidelines recommend to use nsbbs with caution in patients. Six male patients pughs grade a 2, b 2, c 2 with alcoholic cirrhosis received a 25mgh intravenous we read with. They are most often a consequence of portal hypertension, commonly due to cirrhosis.
Current guidelines recommend performing an emergency. Octreotide brand name sandostatin, among others is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. In all patients, vasoconstrictors such as terlipressin or somatostatin are recommended and. To compare the efficacy of terlipressin and octreotide in initial management of acute variceal. Octreotide trade name sandostatin, among others is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than. Prevention and management of gastroesophageal varices and. Sandostatin octreotide acetate dose, indications, adverse. Sclerotherapy with or without octreotide for acute variceal. Variceal bleeding in cirrhotic patients gastroenterology report. Lack of difference among terlipressin, somatostatin, and octreotide. Octreotide for cirrhosis after variceal bleeding the bmj. Sengstaken blakemore tube was required once only in a patient who continue to bleed. The purpose of this study was to establish octreotide or terlipressin, as the first line of pharmacological therapies in controlling acute variceal bleeding, particularly where the facilities for ligation and banding. Comparison of terlipressin, somatostatin, and octreotide.
Octreotide versus terlypressin in acute variceal hemorrhage. Subcutaneous octreotide for the prevention of early variceal rebleeding to the editor. The objective of the study was to evaluate the efficacy of intravenous octreotide following sclerotherapy in prevention of early variceal rebleeding. Octreotide and terlipressin are probably the two most commonly used drugs worldwide to reduce the rate of acute bleeding from gastroesophageal varices in patients with portal hypertension 15. Octreotide was administered as a continuous infusion 50 mcghr for 48 hours.
By continuing to browse this site you are agreeing to our use of cookies. In total, 780 patients with variceal bleeding were enrolled. In preparing this document, a search of the medical literature was. Recent data suggesting that octreotide combination to betablockers or sclerotherapy may represent a useful approach for longterm prevention of rebleeding in these patients will have to be confirmed.
Subcutaneous octreotide for the prevention of early. Logistic regression analysis, incorporating all the characteristics in table 1 indicated that the factors independently associated with survival without rebleeding at 5 days were the treatment assigned. Somatostatin in acute bleeding oesophageal varices. This study is performed to compare the efficacy of terlipressin, somatostatin, and octreotide in patients. Sclerotherapy with or without octreotide for acute. Sclerotherapy with or without somatostatin or octreotide in the treatment of acute variceal haemorrhage. You have free access to this content hepatology volume 46, issue 3, version of record online. The safety of octreotide in patients with variceal bleeding, which has recently been challenged, should be assessed in larger trials. Somatostatin or oclreotide remain the best candidates for the optimal drug tiudtment for acute variceal bleed ing due to the simplicity of administration and lack of side effects, but further clinical studies are needed to confirm iheir benefit in the emergency management of variceal bleeding references 1 wahren j, fleig g. Sixty patients with endoscopically confirmed active variceal bleeding entered a randomized controlled clinical trial aimed at comparing the efficacy of octreotide vs. Variceal bleeding is a major complication of portal hypertension and represents a leading cause of death in patients with cirrhosis1,2. The results of a recent metaanalysis, combining the data of 23 trials, show a. Vasoactive drugs such as terlipressin, somatostatin, and octreotide have a leading role in the management of variceal bleeding since they improve the control of bleeding and consequently reduce.
It is suggested that periodic quantitative 72hour fecal fat and serum carotene determinations be performed to aid in the. This offlabel use of octreotide has an uncertain mechanism of action but appears effective in reducing or stopping variceal bleeding. Therefore, the management of the patient with cirrhosis and portal hypertensive gastrointestinal bleeding depends on the phase of portal hypertension at which the patient is situated, from the patient with cirrhosis and portal hypertension who has not yet developed varices to the patient with acute variceal hemorrhage for whom the objective is to. The role of endoscopy in the management of variceal hemorrhage. There was no significant difference in bleeding control at 48 hours between the es only group and the octreotide group 82% versus 85% 16. In the european acute bleeding oesophageal variceal episodes above trial at the end of 5 days, active bleeding from esophageal varices was less frequent in the octreotide group. Should i consider octreotide in my patient with non. The role of endoscopy in the management of variceal. Aug 25, 2010 octreotide is used to control variceal bleeding. Variceal bleeding is a major complication of portal hypertension and.
This study statistically pooled existing trials to evaluate. Once initiated, octreotide should be maintained for. Early variceal rebleed within 10 days after sclerotherapy is a problem7. Somatostatin was originally isolated from the hypothalamus, but has subsequently been found throughout the whole gastrointestinal tract. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal. Its effect lasts approximately 24 hours, because the haemostatic layer sloughs off. This study was aimed to see the efficacy of intravenous octreotide in prevention of early re bleed. Subcutaneous octreotide for the prevention of early variceal. In this study the investigators determined whether a longacting preparation of octreotide sandostatin largiven as an intramuscular injection every month could decrease portal pressure, and thus be. The purpose of this study was to establish octreotide or terlipressin, as the first line of pharmacological therapies in controlling acute variceal bleeding, particularly where the facilities for ligation and banding are not available objectives. Variceal bleeding is one of the major causes of death in cirrhotic patients.
Octreotide is an analog of somatostatin with a half. Varices, gastroesophageal, bleeding treatment octreotide, with an appropriate adjunctive therapeutic intervention such as sclerotherapy, is indicated to control bleeding and early rebleeding and to reduce transfusion requirements in patients with bleeding gastroesophageal varices associated with cirrhosis. The only placebocontrolled trial, published in abstract, failed to show. Octreotide infusion or emergency sclerotherapy for. However, it is still unclear whether the efficacies of these drugs are same or not. To prevent further bleeding the drug should be continued for two to five days after endoscopic variceal. This study statistically pooled existing trials to evaluate the safety and efficacy of octreotide for esophageal variceal hemorrhage. Sclerotherapy with or without somatostatin or octreotide in the treatment of acute variceal. In all patients, vasoconstrictors such as terlipressin or somatostatin are. It was first synthesized in 1979, by the chemist wilfried bauer. Patients responding to subcutaneous octreotide may initiate with 20 mg depot injection suspension im every 4 weeks for 3 months. Efficacy of longacting octreotide sandostatin lar in. The role of endoscopy in the management of variceal hemorrhage this is one of a series of statements discussing the use of gi endoscopy in common clinical situations. Onehundred eleven patients were randomized to receive octreotide and 107 received placebo.
Whether it is the primary reason for admission or a complication of critical illness, upper gastrointestinal bleeding is commonly encountered in the intensive care unit. Sep 25, 2017 octreotide is routinely used in the treatment of variceal bleeding due to its vasoconstrictive effects on the splanchnic vasculature. Acute hemodynamic effects of octreotide and terlipressin in. Comparison of terlipressin, somatostatin, and octreotide for. Octreotide a strong case can be made for instituting therapy with octreotide a synthetic somatostatin analog whenever variceal hemorrhage is suspected.
Pharmacological rationale for the use of somatostatin and. Once initiated, octreotide should be maintained for 2 to 5. Who should have surveillance for variceal bleeding. Then initial clinical, biochemical, and hematologic assessment was carried out and the patients were graded according to childs. All patients in the octreotide group received es at the end of the 48hour infusion. For suspected variceal bleeding an octreotide infusion should be initiated immediately. However, two recent studies by ibrahim et al have shown that hemospray could be employed in active variceal bleeding as a bridge to a definitive treatment40,41. Should i consider octreotide in my patient with nonvariceal. A meta analysis studies of octreotide have not demonstrated a consistent benefit in efficacy. It is believed that both drugs act as mesenteric vasoconstrictors, thus reducing portal venous. Currently, it is only licensed for the treatment of nonvariceal upper gi bleed. Acute hemodynamic effects of octreotide and terlipressin. It is currently recommended to combine pharmacological and.
Somatostatin in acute bleeding oesophageal varices springerlink. Patients with shock and those with active bleeding are more likely to benefit from this combined therapy. The standards of practice committee of the american society for gastrointestinal endoscopy prepared this text. Diagnostic and therapeutic developments have led to a significant improvement in the prognosis of this complication over the past two decades. In patients with recent bleeding, there was no significant difference in hemostasis between es and octreotide at 48 hours. Hwang sj, lin hc, chang cf, lee fy, lu cw, hsia hc, wang ss, lee sd, tsai yt, lo kj. Vasoactive drugs preferable somatostatin or terlipressin should be started as soon as a variceal bleeding is. Octreotide use as an adjunct to endoscopic therapy 21, 24, 32 should be distinguished from its use as an initial therapy awaiting endoscopy.
For the treatment of variceal bleeding or nonvariceal upper gi bleeding. Vi guidelines recommended to monitor sodium levels in patients on terlipressin. Nov 28, 2012 somatostatin was originally isolated from the hypothalamus, but has subsequently been found throughout the whole gastrointestinal tract. Uk guidelines on the management of variceal haemorrhage in. The role of combining vasoactive drugs with endoscopic therapy vbl or sclerotherapy was. The vasoconstrictors somatostatin and octreotide are used to treat acute bleeding in patients with portal hypertension before performing endoscopy.
220 1251 93 627 75 1390 409 1401 753 1069 1057 274 1003 939 1236 839 1437 112 1356 1579 1574 503 762 54 588 542 1061 49 159 423 459 742 639 1030 1479 1302 761 981